Shilpi Anand, MD
Allergy/Immunology · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 2
- Since medical school
- 26 years
- Albany Medical College of Union University, 2000
Offices
2 locations · Allergy and Asthma Clinic Incorporated · Allergy and Asthma Medical Group of the Bay Area Inc
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anand’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104906 · Current
Licensed to practise in California · since 2008 · expires 2028-03-31 · Albany Medical College of Union University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Allergy and Immunology - Allergy and Immunology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$207,642
Medicare paid this office $207,642 for 122 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 78 | $16,657 | $113 |
| New patient visit (45+ min) | 42 | $6,223 | $148 |
| Test for allergy using allergenic extract | 30 | $5,311 | $3 |
| Professional service for multiple injections of allergen | 22 | $4,550 | $13 |
| Professional service for preparation and provision of 1 or more antigens | 24 | $4,123 | $12 |
See all 10 services
| Return visit (30+ min) | 78 | $16,657 | $113 |
| New patient visit (45+ min) | 42 | $6,223 | $148 |
| Test for allergy using allergenic extract | 30 | $5,311 | $3 |
| Professional service for multiple injections of allergen | 22 | $4,550 | $13 |
| Professional service for preparation and provision of 1 or more antigens | 24 | $4,123 | $12 |
| Test to measure expiratory airflow and volume | 54 | $2,433 | $26 |
| Test to measure the level of nitric oxide gas | 57 | $1,975 | $20 |
| Short return visit (20+ min) | 11 | $894 | $81 |
| Test for allergy using allergenic extract injected into skin | 17 | $510 | $8 |
| Administration and interpretation of patient-focused health risk assessment | 31 | $116 | $3 |
Who their Medicare patients are
122 Original Medicare patients in 2024. Average age 73 · Women 62% · Health risk score 0.96. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 66% · Depression 20% · Coronary heart disease 17% · Chronic kidney disease 16% · Cancer 16% · Diabetes 14% · COPD 14% · Atrial fibrillation 11%.
The office billed $515,328, Medicare allowed $266,854 and paid $207,642; for 8,598 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 122 | 8,598 | 73 | 0.96 | $515,328 | $207,642 |
| 2023 | 96 | 5,227 | 72 | 1.04 | $331,270 | $135,995 |
| 2022 | 81 | 3,143 | 72 | 0.91 | $215,022 | $94,343 |
| 2021 | 82 | 5,593 | 71 | 0.81 | $360,281 | $149,067 |
| 2020 | 83 | 5,815 | 71 | 0.88 | $356,549 | $137,094 |
| 2019 | 64 | 1,924 | 71 | 0.79 | $109,415 | $41,849 |
| 2018 | 95 | 1,887 | 72 | 0.94 | $101,405 | $35,724 |
| 2017 | 77 | 1,647 | 71 | 0.88 | $82,072 | $29,571 |
| 2016 | 109 | 2,325 | 71 | 0.93 | $102,805 | $34,874 |
| 2015 | 108 | 3,249 | 71 | 0.96 | $140,088 | $54,682 |
| 2014 | 82 | 2,402 | 71 | 0.85 | $107,924 | $42,888 |
| 2013 | 81 | 1,553 | 70 | 0.84 | $89,522 | $32,224 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 68 | $12,188 | $99 |
| New patient visit (45+ min) | 27 | $4,091 | $152 |
| Test for allergy using allergenic extract | 22 | $3,810 | $4 |
| Professional service for preparation and provision of 1 or more antigens | 23 | $3,420 | $15 |
| Professional service for multiple injections of allergen | 20 | $3,222 | $11 |
| Test to measure expiratory airflow and volume | 30 | $1,130 | $26 |
| Test to measure the level of nitric oxide gas | 31 | $916 | $19 |
| Test for allergy using allergenic extract injected into skin | 17 | $552 | $9 |
| Administration and interpretation of patient-focused health risk assessment | 30 | $152 | $3 |
2022: 8 services
| Return visit (30+ min) | 49 | $8,408 | $92 |
| Professional service for multiple injections of allergen | 21 | $2,770 | $10 |
| Professional service for preparation and provision of 1 or more antigens | 21 | $2,769 | $13 |
| Test for allergy using allergenic extract | 11 | $1,793 | $4 |
| New patient visit (45+ min) | 13 | $1,734 | $133 |
| Short return visit (20+ min) | 11 | $783 | $65 |
| Test to measure expiratory airflow and volume | 13 | $368 | $26 |
| Test to measure the level of nitric oxide gas | 12 | $293 | $20 |
2021: 6 services
| Return visit (30+ min) | 61 | $10,241 | $104 |
| Professional service for preparation and provision of 1 or more antigens | 16 | $3,121 | $14 |
| New patient visit (45+ min) | 21 | $2,865 | $136 |
| Professional service for multiple injections of allergen | 20 | $2,500 | $10 |
| Test for allergy using allergenic extract | 11 | $1,992 | $4 |
| Short return visit (20+ min) | 14 | $1,003 | $72 |
2020: 7 services
| Return visit (30+ min) | 61 | $13,341 | $95 |
| New patient visit (45+ min) | 19 | $2,467 | $130 |
| Professional service for multiple injections of allergen | 19 | $2,060 | $10 |
| Professional service for preparation and provision of 1 or more antigens | 11 | $1,924 | $15 |
| Test for allergy using allergenic extract | 12 | $1,067 | $3 |
| Test to measure expiratory airflow and volume | 17 | $584 | $28 |
| Test to measure the level of nitric oxide gas | 18 | $456 | $18 |
2019: 6 services
| Return visit (30+ min) | 42 | $6,211 | $93 |
| Professional service for multiple injections of allergen | 19 | $2,538 | $10 |
| New patient visit (45+ min) | 12 | $1,844 | $154 |
| Test for allergy using allergenic extract | 12 | $1,625 | $4 |
| Test to measure expiratory airflow and volume | 33 | $1,602 | $32 |
| Test to measure the level of nitric oxide gas | 32 | $1,047 | $21 |
2018: 7 services
| Return visit (30+ min) | 70 | $12,532 | $94 |
| New patient visit (45+ min) | 24 | $3,340 | $139 |
| Test for allergy using allergenic extract | 17 | $3,231 | $5 |
| Test to measure expiratory airflow and volume | 45 | $3,061 | $36 |
| Professional service for multiple injections of allergen | 18 | $2,950 | $9 |
| Test to measure the level of nitric oxide gas | 46 | $1,819 | $21 |
| Test for allergy using allergenic extract injected into skin | 13 | $389 | $8 |
2017: 8 services
| Return visit (30+ min) | 55 | $8,623 | $93 |
| Test for allergy using allergenic extract | 16 | $4,338 | $7 |
| New patient visit (45+ min) | 21 | $3,103 | $148 |
| Professional service for preparation and provision of 1 or more antigens | 20 | $2,759 | $12 |
| Professional service for multiple injections of allergen | 15 | $2,481 | $9 |
| Test to measure expiratory airflow and volume | 36 | $2,470 | $35 |
| Test to measure the level of nitric oxide gas | 37 | $1,397 | $19 |
| Test for allergy using allergenic extract injected into skin | 12 | $285 | $8 |
2016: 8 services
| Return visit (30+ min) | 74 | $8,638 | $81 |
| Test for allergy using allergenic extract | 32 | $7,191 | $6 |
| New patient visit (45+ min) | 44 | $5,581 | $127 |
| Professional service for preparation and provision of 1 or more antigens | 16 | $2,281 | $12 |
| Professional service for multiple injections of allergen | 16 | $2,274 | $9 |
| Test to measure expiratory airflow and volume | 47 | $2,014 | $31 |
| Test to measure the level of nitric oxide gas | 45 | $1,246 | $18 |
| Test for allergy using allergenic extract injected into skin | 24 | $510 | $8 |
2015: 8 services
| Return visit (30+ min) | 71 | $11,350 | $84 |
| Test for allergy using allergenic extract | 38 | $9,474 | $6 |
| New patient visit (45+ min) | 46 | $6,209 | $135 |
| Test to measure expiratory airflow and volume | 49 | $3,105 | $32 |
| Professional service for multiple injections of allergen | 18 | $2,730 | $9 |
| Test to measure the level of nitric oxide gas | 45 | $1,803 | $19 |
| Professional service for preparation and provision of 1 or more antigens | 12 | $1,756 | $12 |
| Test for allergy using allergenic extract injected into skin | 31 | $744 | $8 |
2014: 7 services
| Return visit (30+ min) | 55 | $10,249 | $92 |
| Test for allergy using allergenic extract | 27 | $6,929 | $6 |
| New patient visit (45+ min) | 39 | $5,452 | $140 |
| Test to measure expiratory airflow and volume | 35 | $2,508 | $34 |
| Test to measure the level of nitric oxide gas | 37 | $1,508 | $19 |
| Professional service for multiple injections of allergen | 12 | $952 | $9 |
| Test for allergy using allergenic extract injected into skin | 22 | $637 | $7 |
2013: 8 services
| Return visit (30+ min) | 55 | $11,056 | $92 |
| New patient visit (45+ min) | 47 | $6,307 | $134 |
| Test for allergy using allergenic extract | 26 | $5,444 | $6 |
| Test to measure expiratory airflow and volume | 30 | $2,188 | $35 |
| Test to measure the level of nitric oxide gas | 33 | $1,296 | $20 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $926 | $62 |
| Short return visit (20+ min) | 13 | $914 | $61 |
| Test for allergy using allergenic extract injected into skin | 19 | $811 | $8 |
Drugs they prescribed that Part D paid
$144,365
Pharmacies billed $144,365 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 482) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
271 generic and 211 brand-name prescriptions · $144,365 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 13 | $45,892 | $3,530 |
| Trelegy Ellipta | 26 | $19,543 | $752 |
| Breo Ellipta | 38 | $17,984 | $473 |
| Dulera | 13 | $4,675 | $360 |
| Tudorza Pressair | 12 | $3,070 | $256 |
See all 15 drugs
| Dupixent | 13 | $45,892 | $3,530 |
| Trelegy Ellipta | 26 | $19,543 | $752 |
| Breo Ellipta | 38 | $17,984 | $473 |
| Dulera | 13 | $4,675 | $360 |
| Tudorza Pressair | 12 | $3,070 | $256 |
| Epinephrine | 20 | $2,794 | $140 |
| Azelastine-Fluticasone | 18 | $1,755 | $97 |
| Azelastine | 43 | $1,262 | $29 |
| Ipratropium | 28 | $867 | $31 |
| Levalbuterol Tartrate Hfa | 11 | $629 | $57 |
| Montelukast | 77 | $460 | $6 |
| Albuterol Sulfate Hfa | 14 | $423 | $30 |
| Hydroxyzine | 11 | $215 | $20 |
| Fluticasone Propionate | 17 | $102 | $6 |
| Prednisone | 19 | $62 | $3 |
Year by year
| 2024 | 482 | 99 | 0% (0) | 44% | $144,365 |
| 2023 | 373 | 73 | 0% (0) | 54% | $103,447 |
| 2022 | 479 | 77 | 0% (0) | 51% | $117,316 |
| 2021 | 487 | 75 | 0% (0) | 52% | $134,255 |
| 2020 | 442 | 72 | 0% (0) | 48% | $99,760 |
| 2019 | 217 | 51 | 0% (0) | 42% | $40,392 |
| 2018 | 307 | 73 | 0% (0) | 44% | $53,795 |
| 2017 | 252 | 64 | 0% (0) | 44% | $47,603 |
| 2016 | 372 | 90 | 0% (0) | 48% | $53,833 |
| 2015 | 444 | 89 | 0% (0) | 49% | $60,414 |
| 2014 | 337 | 66 | 0% (0) | 44% | $35,987 |
| 2013 | 254 | 69 | 0% (0) | 43% | $26,784 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Breo Ellipta | 40 | $19,310 | $483 |
| Trelegy Ellipta | 11 | $11,147 | $1,013 |
| Dulera | 16 | $7,505 | $469 |
| Spiriva Respimat | 11 | $5,993 | $545 |
| Flovent Hfa | 23 | $5,744 | $250 |
| Tudorza Pressair | 11 | $3,467 | $315 |
| Epinephrine | 14 | $2,813 | $201 |
| Azelastine-Fluticasone | 15 | $1,415 | $94 |
| Albuterol Sulfate Hfa | 20 | $817 | $41 |
| Montelukast | 68 | $774 | $11 |
| Azelastine | 11 | $631 | $57 |
| Ipratropium | 17 | $450 | $26 |
2022: 14 drugs
| Breo Ellipta | 34 | $17,154 | $505 |
| Advair Hfa | 11 | $10,470 | $952 |
| Incruse Ellipta | 16 | $9,102 | $569 |
| Flovent Hfa | 30 | $8,564 | $285 |
| Spiriva Respimat | 12 | $6,366 | $531 |
| Dulera | 12 | $4,165 | $347 |
| Azelastine-Fluticasone | 15 | $1,786 | $119 |
| Montelukast | 90 | $1,513 | $17 |
| Olopatadine | 13 | $1,438 | $111 |
| Azelastine | 13 | $1,227 | $94 |
| Ipratropium | 34 | $930 | $27 |
| Albuterol Sulfate Hfa | 13 | $520 | $40 |
| Fluticasone Propionate | 14 | $443 | $32 |
| Azithromycin | 12 | $357 | $30 |
2021: 17 drugs
| Xolair | 11 | $28,136 | $2,558 |
| Breo Ellipta | 41 | $22,118 | $539 |
| Advair Hfa | 17 | $12,691 | $747 |
| Dulera | 27 | $8,438 | $313 |
| Incruse Ellipta | 16 | $8,250 | $516 |
| Flovent Hfa | 24 | $7,420 | $309 |
| Spiriva Respimat | 13 | $6,362 | $489 |
| Symbicort | 13 | $5,298 | $408 |
| Azelastine-Fluticasone | 13 | $2,373 | $183 |
| Arnuity Ellipta | 11 | $2,157 | $196 |
| Montelukast | 101 | $1,487 | $15 |
| Azelastine | 20 | $1,363 | $68 |
| Albuterol Sulfate Hfa | 16 | $540 | $34 |
| Ipratropium | 19 | $439 | $23 |
| Pantoprazole | 12 | $241 | $20 |
| Fluticasone Propionate | 11 | $98 | $9 |
| Prednisone | 12 | $62 | $5 |
2020: 13 drugs
| Breo Ellipta | 39 | $23,678 | $607 |
| Advair Diskus | 17 | $11,661 | $686 |
| Advair Hfa | 13 | $10,073 | $775 |
| Dulera | 27 | $8,263 | $306 |
| Spiriva Respimat | 14 | $6,237 | $446 |
| Flovent Hfa | 15 | $4,352 | $290 |
| Arnuity Ellipta | 12 | $3,251 | $271 |
| Montelukast | 102 | $1,497 | $15 |
| Azelastine | 19 | $1,115 | $59 |
| Fluticasone Propionate | 13 | $335 | $26 |
| Azithromycin | 11 | $308 | $28 |
| Pantoprazole | 14 | $99 | $7 |
| Prednisone | 12 | $54 | $4 |
2019: 5 drugs
| Flovent Hfa | 14 | $3,286 | $235 |
| Arnuity Ellipta | 12 | $2,498 | $208 |
| Azelastine | 18 | $1,193 | $66 |
| Montelukast | 52 | $1,140 | $22 |
| Fluticasone Propionate | 11 | $144 | $13 |
2018: 9 drugs
| Flovent Hfa | 25 | $5,893 | $236 |
| Dymista | 14 | $2,582 | $184 |
| Azelastine | 30 | $2,185 | $73 |
| Arnuity Ellipta | 13 | $2,169 | $167 |
| Ipratropium | 12 | $950 | $79 |
| Montelukast | 58 | $785 | $14 |
| Azithromycin | 12 | $429 | $36 |
| Fluticasone Propionate | 13 | $157 | $12 |
| Prednisone | 14 | $57 | $4 |
2017: 5 drugs
| Flovent Hfa | 21 | $4,489 | $214 |
| Azelastine | 24 | $1,666 | $69 |
| Ipratropium | 12 | $841 | $70 |
| Montelukast | 53 | $650 | $12 |
| Fluticasone Propionate | 14 | $192 | $14 |
2016: 11 drugs
| Advair Diskus | 14 | $7,473 | $534 |
| Dulera | 12 | $4,300 | $358 |
| Qvar | 20 | $4,126 | $206 |
| Breo Ellipta | 11 | $3,290 | $299 |
| Flovent Hfa | 16 | $2,829 | $177 |
| Dymista | 12 | $2,465 | $205 |
| Pataday | 12 | $1,919 | $160 |
| Azelastine | 29 | $1,744 | $60 |
| Montelukast | 72 | $1,536 | $21 |
| Ipratropium | 15 | $567 | $38 |
| Fluticasone Propionate | 24 | $346 | $14 |
2015: 14 drugs
| Advair Hfa | 25 | $10,708 | $428 |
| Spiriva | 14 | $5,016 | $358 |
| Qvar | 17 | $4,037 | $237 |
| Advair Diskus | 11 | $3,877 | $352 |
| Dulera | 11 | $3,292 | $299 |
| Pataday | 18 | $2,849 | $158 |
| Azelastine | 47 | $2,801 | $60 |
| Asmanex | 11 | $2,136 | $194 |
| Dymista | 11 | $1,863 | $169 |
| Montelukast | 69 | $1,350 | $20 |
| Proair Hfa | 25 | $1,325 | $53 |
| Fluticasone Propionate | 31 | $449 | $14 |
| Azithromycin | 12 | $277 | $23 |
| Prednisone | 23 | $90 | $4 |
2014: 7 drugs
| Advair Hfa | 19 | $5,802 | $305 |
| Qvar | 21 | $3,685 | $175 |
| Pataday | 19 | $2,680 | $141 |
| Azelastine | 29 | $1,741 | $60 |
| Montelukast | 64 | $1,385 | $22 |
| Fluticasone Propionate | 49 | $747 | $15 |
| Prednisone | 14 | $71 | $5 |
2013: 6 drugs
| Advair Hfa | 11 | $3,877 | $352 |
| Patanase | 19 | $3,548 | $187 |
| Qvar | 19 | $2,703 | $142 |
| Montelukast | 43 | $2,400 | $56 |
| Azelastine | 22 | $1,844 | $84 |
| Fluticasone Propionate | 29 | $621 | $21 |
Money from drug and device companies
$548 in 2025
| 2025 | 6 | 26 | None | $548 |
| 2024 | 15 | 51 | None | $1,207 |
| 2023 | 14 | 49 | None | $1,271 |
| 2022 | 14 | 29 | None | $915 |
| 2021 | 13 | 34 | None | $648 |
| 2020 | 7 | 18 | None | $392 |
| 2019 | 12 | 24 | None | $477 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $207 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $138 | 6 payments
|
| Genzyme | Dupixent | $119 | 4 payments
|
| Galderma Laboratories L.P. | Nemluvio | $47 | 2 payments
|
| ALK-Abello | Grastek | $23 | 1 payment
|
| CSL Behring | Hizentra | $14 | 1 payment
|
See all 25 published payments
| GlaxoSmithKline | Meals · 2025-12-08 | Trelegy Ellipta | $15 |
| GlaxoSmithKline | Meals · 2025-11-17 | Nucala | $28 |
| CSL Behring | Meals · 2025-11-17 | Hizentra | $14 |
| GlaxoSmithKline | Meals · 2025-11-16 | Nucala | $1 |
| Galderma Laboratories L.P. | Meals · 2025-11-04 | Nemluvio | $26 |
| GlaxoSmithKline | Meals · 2025-10-28 | Trelegy Ellipta | $24 |
| GlaxoSmithKline | Meals · 2025-10-18 | Nucala | $28 |
| GlaxoSmithKline | Meals · 2025-10-14 | Trelegy Ellipta | $11 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-06 | Fasenra | $27 |
| GlaxoSmithKline | Meals · 2025-09-16 | Trelegy Ellipta | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-15 | Airsupra | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | Airsupra | $14 |
| Galderma Laboratories L.P. | Meals · 2025-08-04 | Nemluvio | $21 |
| Genzyme | Meals · 2025-07-21 | Dupixent | $32 |
| GlaxoSmithKline | Meals · 2025-07-07 | Nucala | $26 |
| ALK-Abello | Meals · 2025-06-13 | Grastek | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-13 | Breztri | $32 |
| GlaxoSmithKline | Meals · 2025-04-23 | Nucala | $8 |
| Genzyme | Meals · 2025-04-21 | Dupixent | $33 |
| GlaxoSmithKline | Meals · 2025-03-31 | Nucala | $32 |
| Genzyme | Meals · 2025-03-26 | Dupixent | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-17 | Airsupra | $3 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-17 | Tezspire | $29 |
| GlaxoSmithKline | Meals · 2025-02-06 | Nucala | $25 |
| Genzyme | Meals · 2025-01-08 | Dupixent | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,207
| Genzyme | Dupixent | $211 | 7 payments
|
| GlaxoSmithKline | Nucala | $183 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $135 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $132 | 5 payments
|
| kaleo | Auvi-Q | $116 | 3 payments
|
| LEO Pharma | Adbry | $71 | 3 payments
|
| Amgen | Tezspire | $58 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $54 | 2 payments
|
| ALK-Abello | Odactra | $48 | 2 payments
|
| Pharming Healthcare | Ruconest | $47 | 2 payments
|
| Grifols USA | Xembify | $46 | 2 payments
|
| Genentech USA | Xolair | $33 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $29 | 1 payment
|
| Optinose US | Xhance | $27 | 1 payment
|
| Phadia US | Immunocap | $18 | 1 payment
|
2023: $1,271
| ALK-Abello | Odactra | $204 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $183 | 6 payments
|
| GlaxoSmithKline | Nucala | $149 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $135 | 6 payments
|
| Amgen | Tezspire | $103 | 5 payments
|
| kaleo | Auvi-Q | $96 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $87 | 3 payments
|
| Pfizer | Eucrisa | $62 | 2 payments
|
| CSL Behring | Hizentra | $61 | 2 payments
|
| Genzyme | Dupixent | $58 | 2 payments
|
| Octapharma USA | Cutaquig | $43 | 2 payments
|
| Merck Sharp & Dohme | None | $38 | 2 payments
|
| Grifols USA | Xembify | $31 | 1 payment
|
| Genentech USA | Xolair | $23 | 1 payment
|
2022: $915
| ALK-Abello | Odactra | $282 | 4 payments
|
| GlaxoSmithKline | Nucala | $140 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $113 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $63 | 2 payments
|
| Genzyme | Dupixent | $59 | 2 payments
|
| Amgen | Tezspire | $51 | 3 payments
|
| Pfizer | Panzyga | $43 | 2 payments
|
| kaleo | Auvi-Q | $30 | 1 payment
|
| Bio Products Laboratory USA | Gammaplex | $27 | 1 payment
|
| TerSera Therapeutics | Quzyttir | $25 | 1 payment
|
| OptiNose US | Xhance | $24 | 1 payment
|
| Genentech USA | Xolair | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $18 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $17 | 1 payment
|
2021: $648
| AstraZeneca Pharmaceuticals LP | Farxiga | $156 | 6 payments
|
| ALK-Abello | Odactra | $98 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $88 | 5 payments
|
| Covis Pharma GmBH | Alvesco | $71 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $56 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $38 | 1 payment
|
| Uswm | Symjepi | $27 | 1 payment
|
| Grifols USA | Xembify | $23 | 1 payment
|
| Merck Sharp & Dohme | None | $22 | 1 payment
|
| Optinose US | Xhance | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $18 | 1 payment
|
| Genentech USA | Xolair | $17 | 1 payment
|
| Pharming Healthcare | Ruconest | $15 | 1 payment
|
2020: $392
| AstraZeneca Pharmaceuticals LP | Symbicort | $121 | 7 payments
|
| ALK-Abello | Odactra | $74 | 3 payments
|
| Pfizer | Eucrisa | $62 | 2 payments
|
| OptiNose US | Xhance | $58 | 3 payments
|
| Teva Pharmaceuticals USA | Proair Digihaler | $33 | 1 payment
|
| kaleo | Auvi-Q | $23 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $20 | 1 payment
|
2019: $477
| GlaxoSmithKline | Nucala | $62 | 3 payments
|
| Teva Pharmaceuticals USA | Cinqair | $51 | 3 payments
|
| Kaleo | Auvi-Q | $51 | 3 payments
|
| Shire North American Group | Cuvitru | $46 | 2 payments
|
| OptiNose US | Xhance | $43 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $39 | 2 payments
|
| ALK-Abello | Odactra | $38 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $37 | 2 payments
|
| Genzyme | Dupixent | $37 | 2 payments
|
| Grifols USA | Xembify | $24 | 1 payment
|
| CSL Behring | Haegarda | $24 | 1 payment
|
| Novartis Pharmaceuticals | Ilaris | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 69.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871556605
- Licence
- CA A104906California A104906: Current · expires 2028-03-31
- Trained
- Albany Medical College of Union University, 2000 · 26 years ago
- Group
- Allergy and Asthma Clinic Incorporated · Allergy and Asthma Medical Group of the Bay Area Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207KA0200X (207KA0200X)
- Mailing address
- 130 La Casa Via, Suite 209, Walnut Creek, CA, 94598
- NPI first listed
- 2006-04-11
- NPI last updated
- 2012-05-11
This is when the NPI record was last certified, not a medical board exam.